Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
ConocoPhillips
COP
|
+$3.33B |
| 2 |
Merck
MRK
|
+$2.61B |
| 3 |
Schlumberger
SLB
|
+$1.65B |
| 4 |
Target
TGT
|
+$1.34B |
| 5 |
General Mills
GIS
|
+$926M |
Top Sells
| 1 |
Pfizer
PFE
|
+$2.72B |
| 2 |
Blackrock
BLK
|
+$2.48B |
| 3 |
US Bancorp
USB
|
+$1.68B |
| 4 |
M&T Bank
MTB
|
+$762M |
| 5 |
Huntington Bancshares
HBAN
|
+$554M |
Sector Composition
| 1 | Technology | 21.5% |
| 2 | Financials | 11.88% |
| 3 | Healthcare | 10.59% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3226
Foghorn Therapeutics
FHTX
$307M
| $276K | ﹤0.01% |
75,495
| – | – |
|
3227
ADC Therapeutics
ADCT
$373M
| $274K | ﹤0.01% |
194,258
| – | – |
|
3228
Nkarta
NKTX
$147M
| $271K | ﹤0.01% |
147,551
+22,538
| +18% | +$41.5K |
|
|
SBT
3229
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $270K | ﹤0.01% |
55,854
+55
| +0.1% | +$266 |
|
3230
Stereotaxis
STXS
$263M
| $270K | ﹤0.01% |
153,321
+284
| +0.2% | +$500 |
|
3231
Twin Disc
TWIN
$192M
| $269K | ﹤0.01% |
35,531
+3,796
| +12% | +$28.7K |
|
3232
Strawberry Fields REIT
STRW
$152M
| $269K | ﹤0.01% |
22,553
+6,435
| +40% | +$76.6K |
|
3233
PLAYSTUDIOS Inc
MYPS
$120M
| $264K | ﹤0.01% |
208,131
-40,501
| -16% | -$51.4K |
|
3234
Solid Biosciences
SLDB
$389M
| $254K | ﹤0.01% |
68,607
+5,220
| +8% | +$19.3K |
|
3235
Biote Corp
BTMD
$105M
| $252K | ﹤0.01% |
75,738
| – | – |
|
|
TPIC
3236
DELISTED
TPI Composites
TPIC
| $250K | ﹤0.01% |
310,436
-300,933
| -49% | -$243K |
|
3237
Grifois
GRFS
$6.72B
| $244K | ﹤0.01% |
34,302
+1,102
| +3% | +$7.84K |
|
3238
Geospace Technologies
GEOS
$208M
| $240K | ﹤0.01% |
33,321
| – | – |
|
3239
Achieve Life Sciences
ACHV
$159M
| $239K | ﹤0.01% |
89,562
| – | – |
|
3240
On Holding
ONON
$14.5B
| $233K | ﹤0.01% |
+5,296
| New | +$233K |
|
|
PAMT
3241
PAMT CORP Common Stock
PAMT
$239M
| $231K | ﹤0.01% |
19,009
+2,255
| +13% | +$27.4K |
|
3242
Paymentus
PAY
$4.46B
| $228K | ﹤0.01% |
8,752
| – | – |
|
3243
Lineage Cell Therapeutics
LCTX
$290M
| $227K | ﹤0.01% |
503,193
+86,970
| +21% | +$39.3K |
|
3244
Acrivon Therapeutics
ACRV
$51.9M
| $226K | ﹤0.01% |
111,320
-2,520
| -2% | -$5.12K |
|
3245
Cabaletta Bio
CABA
$150M
| $221K | ﹤0.01% |
159,866
+50,606
| +46% | +$70.1K |
|
3246
Northern Technologies International Corp
NTIC
$76.6M
| $220K | ﹤0.01% |
21,176
| – | – |
|
3247
AirSculpt Technologies
AIRS
$387M
| $219K | ﹤0.01% |
93,909
-6,762
| -7% | -$15.8K |
|
3248
XBiotech
XBIT
$85.1M
| $218K | ﹤0.01% |
67,355
+8,918
| +15% | +$28.9K |
|
3249
Marine Products Corp
MPX
$317M
| $216K | ﹤0.01% |
25,788
+1,959
| +8% | +$16.4K |
|
3250
Consumer Portfolio Services
CPSS
$182M
| $216K | ﹤0.01% |
24,927
| – | – |
|